0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Anti-Venom Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-36E16021
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Anti Venom Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Anti-Venom Market Report & Forecast 2023-2029

Code: QYRE-Auto-36E16021
Report
December 2023
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Anti-Venom Market Size

The global Anti-Venom revenue was US$ 959.2 million in 2022 and is forecast to a readjusted size of US$ 1283.7 million by 2029 with a CAGR of 4.2% during the forecast period (2023-2029).

and India Anti-Venom Market

and India Anti-Venom Market

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.
In India, the Anti-Venom revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
This report focuses on global and India Anti-Venom market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Anti-Venom will continue to grow rapidly in the future.
Global Anti-Venom Scope and Market Size
Anti-Venom market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Anti-Venom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Anti-Venom market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Anti-Venom Market Report

Report Metric Details
Report Name and India Anti-Venom Market
Forecasted market size in 2029 US$ 1283.7 million
CAGR 4.2%
Forecasted years 2023 - 2029
Segment by Type
  • Polyvalent Anti-Venom
  • Monovalent Anti-Venom
Segment by Application
  • Non-profit Institutions
  • Hospitals and Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Anti-Venom Market size in 2029?

Ans: The and India Anti-Venom Market size in 2029 will be US$ 1283.7 million.

What is the CSL, Merck, BTG, Pfizer, Haffkine Bio Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm share in and India Anti-Venom Market?

Ans: CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm.

What is the and India Anti-Venom Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Anti-Venom Market report?

Ans: The main players in the and India Anti-Venom Market are CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm

What are the Application segmentation covered in the and India Anti-Venom Market report?

Ans: The Applications covered in the and India Anti-Venom Market report are Non-profit Institutions, Hospitals and Clinic

What are the Type segmentation covered in the and India Anti-Venom Market report?

Ans: The Types covered in the and India Anti-Venom Market report are Polyvalent Anti-Venom, Monovalent Anti-Venom

1 Study Coverage
1.1 Anti-Venom Product Introduction
1.2 Global Anti-Venom Outlook 2018 VS 2022 VS 2029
1.2.1 Global Anti-Venom Sales in US$ Million for the Year 2018-2029
1.2.2 Global Anti-Venom Sales in Volume for the Year 2018-2029
1.3 India Anti-Venom Outlook 2018 VS 2022 VS 2029
1.3.1 India Anti-Venom Sales in US$ Million for the Year 2018-2029
1.3.2 India Anti-Venom Sales in Volume for the Year 2018-2029
1.4 Anti-Venom Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Anti-Venom in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Anti-Venom Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Anti-Venom Market Dynamics
1.5.1 Anti-Venom Industry Trends
1.5.2 Anti-Venom Market Drivers
1.5.3 Anti-Venom Market Challenges
1.5.4 Anti-Venom Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Anti-Venom by Type
2.1 Anti-Venom Market Segment by Type
2.1.1 Polyvalent Anti-Venom
2.1.2 Monovalent Anti-Venom
2.2 Global Anti-Venom Market Size by Type
2.2.1 Global Anti-Venom Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Anti-Venom Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Anti-Venom Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Anti-Venom Market Size by Type
2.3.1 India Anti-Venom Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Anti-Venom Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Anti-Venom Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Anti-Venom by Application
3.1 Anti-Venom Market Segment by Application
3.1.1 Non-profit Institutions
3.1.2 Hospitals and Clinic
3.2 Global Anti-Venom Market Size by Application
3.2.1 Global Anti-Venom Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Anti-Venom Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Anti-Venom Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Anti-Venom Market Size by Application
3.3.1 India Anti-Venom Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Anti-Venom Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Anti-Venom Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Anti-Venom Competitor Landscape by Company
4.1 Global Anti-Venom Market Size by Company
4.1.1 Global Key Manufacturers of Anti-Venom, Ranked by Revenue (2022)
4.1.2 Global Anti-Venom Revenue by Manufacturer (2018-2023)
4.1.3 Global Anti-Venom Sales by Manufacturer (2018-2023)
4.1.4 Global Anti-Venom Price by Manufacturer (2018-2023)
4.2 Global Anti-Venom Concentration Ratio (CR)
4.2.1 Anti-Venom Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Venom in 2022
4.2.3 Global Anti-Venom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Anti-Venom, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Anti-Venom, Product Offered and Application
4.5 Global Key Manufacturers of Anti-Venom, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Anti-Venom Market Size by Company
4.7.1 Key Players of Anti-Venom in India, Ranked by Revenue (2022)
4.7.2 India Anti-Venom Revenue by Players (2018-2023)
4.7.3 India Anti-Venom Sales by Players (2018-2023)
5 Global Anti-Venom Market Size by Region
5.1 Global Anti-Venom Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Anti-Venom Market Size in Volume by Region (2018-2029)
5.2.1 Global Anti-Venom Sales in Volume by Region: 2018-2023
5.2.2 Global Anti-Venom Sales in Volume Forecast by Region (2024-2029)
5.3 Global Anti-Venom Market Size in Value by Region (2018-2029)
5.3.1 Global Anti-Venom Sales in Value by Region: 2018-2023
5.3.2 Global Anti-Venom Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Anti-Venom Market Size YoY Growth 2018-2029
6.2 Americas Anti-Venom Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Anti-Venom Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Anti-Venom Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Anti-Venom Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Anti-Venom Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Anti-Venom Market Size YoY Growth 2018-2029
7.2 EMEA Anti-Venom Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Anti-Venom Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Anti-Venom Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Anti-Venom Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Anti-Venom Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Anti-Venom Market Size YoY Growth 2018-2029
8.2 China Anti-Venom Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Anti-Venom Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Anti-Venom Market Size YoY Growth 2018-2029
9.2 APAC Anti-Venom Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Anti-Venom Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Anti-Venom Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Anti-Venom Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Anti-Venom Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 CSL
10.1.1 CSL Company Information
10.1.2 CSL Description and Business Overview
10.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CSL Anti-Venom Products Offered
10.1.5 CSL Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Description and Business Overview
10.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Anti-Venom Products Offered
10.2.5 Merck Recent Development
10.3 BTG
10.3.1 BTG Company Information
10.3.2 BTG Description and Business Overview
10.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BTG Anti-Venom Products Offered
10.3.5 BTG Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Description and Business Overview
10.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Anti-Venom Products Offered
10.4.5 Pfizer Recent Development
10.5 Haffkine Bio-Pharmaceutical
10.5.1 Haffkine Bio-Pharmaceutical Company Information
10.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
10.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Products Offered
10.5.5 Haffkine Bio-Pharmaceutical Recent Development
10.6 Rare Disease Therapeutics
10.6.1 Rare Disease Therapeutics Company Information
10.6.2 Rare Disease Therapeutics Description and Business Overview
10.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Rare Disease Therapeutics Anti-Venom Products Offered
10.6.5 Rare Disease Therapeutics Recent Development
10.7 Flynn Pharma
10.7.1 Flynn Pharma Company Information
10.7.2 Flynn Pharma Description and Business Overview
10.7.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Flynn Pharma Anti-Venom Products Offered
10.7.5 Flynn Pharma Recent Development
10.8 Vins Bioproducts
10.8.1 Vins Bioproducts Company Information
10.8.2 Vins Bioproducts Description and Business Overview
10.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Vins Bioproducts Anti-Venom Products Offered
10.8.5 Vins Bioproducts Recent Development
10.9 Bharat Serums and Vaccines
10.9.1 Bharat Serums and Vaccines Company Information
10.9.2 Bharat Serums and Vaccines Description and Business Overview
10.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bharat Serums and Vaccines Anti-Venom Products Offered
10.9.5 Bharat Serums and Vaccines Recent Development
10.10 Serum Biotech
10.10.1 Serum Biotech Company Information
10.10.2 Serum Biotech Description and Business Overview
10.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Serum Biotech Anti-Venom Products Offered
10.10.5 Serum Biotech Recent Development
10.11 MicroPharm
10.11.1 MicroPharm Company Information
10.11.2 MicroPharm Description and Business Overview
10.11.3 MicroPharm Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
10.11.4 MicroPharm Anti-Venom Products Offered
10.11.5 MicroPharm Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Anti-Venom Industry Chain Analysis
11.2 Anti-Venom Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Anti-Venom Production Mode & Process
11.4 Anti-Venom Sales and Marketing
11.4.1 Anti-Venom Sales Channels
11.4.2 Anti-Venom Distributors
11.5 Anti-Venom Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Anti-Venom CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Anti-Venom Market Trends
    Table 3. Anti-Venom Market Drivers
    Table 4. Anti-Venom Market Challenges
    Table 5. Anti-Venom Market Restraints
    Table 6. Global Anti-Venom Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Anti-Venom Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Anti-Venom Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Anti-Venom Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Anti-Venom, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Anti-Venom Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Anti-Venom Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Anti-Venom Sales by Manufacturer, (K Vials), 2018-2023
    Table 14. Global Anti-Venom Sales Share by Manufacturer, 2018-2023
    Table 15. Global Anti-Venom Price by Manufacturer (2018-2023) & (USD/Vial)
    Table 16. Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-Venom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Venom as of 2022)
    Table 18. Global Key Manufacturers of Anti-Venom, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Anti-Venom, Product Offered and Application
    Table 20. Global Key Manufacturers of Anti-Venom, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Anti-Venom in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Anti-Venom Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Anti-Venom Revenue Share by Players, (2018-2023)
    Table 25. India Anti-Venom Sales by Players, (K Vials), (2018-2023)
    Table 26. India Anti-Venom Sales Share by Players, (2018-2023)
    Table 27. Global Anti-Venom Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Anti-Venom Sales in Volume by Region (2018-2023) & (K Vials)
    Table 29. Global Anti-Venom Sales in Volume Forecast by Region (2024-2029) & (K Vials)
    Table 30. Global Anti-Venom Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Anti-Venom Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Anti-Venom Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Anti-Venom Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Anti-Venom Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Anti-Venom Sales in Volume by Country (2018-2023) & (K Vials)
    Table 36. Americas Anti-Venom Sales in Volume by Country (2024-2029) & (K Vials)
    Table 37. EMEA Anti-Venom Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Anti-Venom Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Anti-Venom Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Anti-Venom Sales in Volume by Country (2018-2023) & (K Vials)
    Table 41. EMEA Anti-Venom Sales in Volume by Country (2024-2029) & (K Vials)
    Table 42. APAC Anti-Venom Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Anti-Venom Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Anti-Venom Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Anti-Venom Sales in Volume by Country (2018-2023) & (K Vials)
    Table 46. APAC Anti-Venom Sales in Volume by Country (2024-2029) & (K Vials)
    Table 47. CSL Company Information
    Table 48. CSL Description and Business Overview
    Table 49. CSL Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 50. CSL Anti-Venom Product
    Table 51. CSL Recent Development
    Table 52. Merck Company Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 55. Merck Anti-Venom Product
    Table 56. Merck Recent Development
    Table 57. BTG Company Information
    Table 58. BTG Description and Business Overview
    Table 59. BTG Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 60. BTG Anti-Venom Product
    Table 61. BTG Recent Development
    Table 62. Pfizer Company Information
    Table 63. Pfizer Description and Business Overview
    Table 64. Pfizer Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 65. Pfizer Anti-Venom Product
    Table 66. Pfizer Recent Development
    Table 67. Haffkine Bio-Pharmaceutical Company Information
    Table 68. Haffkine Bio-Pharmaceutical Description and Business Overview
    Table 69. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 70. Haffkine Bio-Pharmaceutical Anti-Venom Product
    Table 71. Haffkine Bio-Pharmaceutical Recent Development
    Table 72. Rare Disease Therapeutics Company Information
    Table 73. Rare Disease Therapeutics Description and Business Overview
    Table 74. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 75. Rare Disease Therapeutics Anti-Venom Product
    Table 76. Rare Disease Therapeutics Recent Development
    Table 77. Flynn Pharma Company Information
    Table 78. Flynn Pharma Description and Business Overview
    Table 79. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 80. Flynn Pharma Anti-Venom Product
    Table 81. Flynn Pharma Recent Development
    Table 82. Vins Bioproducts Company Information
    Table 83. Vins Bioproducts Description and Business Overview
    Table 84. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 85. Vins Bioproducts Anti-Venom Product
    Table 86. Vins Bioproducts Recent Development
    Table 87. Bharat Serums and Vaccines Company Information
    Table 88. Bharat Serums and Vaccines Description and Business Overview
    Table 89. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 90. Bharat Serums and Vaccines Anti-Venom Product
    Table 91. Bharat Serums and Vaccines Recent Development
    Table 92. Serum Biotech Company Information
    Table 93. Serum Biotech Description and Business Overview
    Table 94. Serum Biotech Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 95. Serum Biotech Anti-Venom Product
    Table 96. Serum Biotech Recent Development
    Table 97. MicroPharm Company Information
    Table 98. MicroPharm Description and Business Overview
    Table 99. MicroPharm Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 100. MicroPharm Anti-Venom Product
    Table 101. MicroPharm Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Anti-Venom Customers List
    Table 105. Anti-Venom Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Venom Product Picture
    Figure 2. Global Anti-Venom Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Anti-Venom Market Size 2018-2029 (US$ Million)
    Figure 4. Global Anti-Venom Sales 2018-2029 (K Vials)
    Figure 5. India Anti-Venom Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Anti-Venom Market Size 2018-2029 (US$ Million)
    Figure 7. India Anti-Venom Sales 2018-2029 (K Vials)
    Figure 8. India Anti-Venom Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Anti-Venom Market Share in Global, in Volume (K Vials) 2018-2029
    Figure 10. Anti-Venom Report Years Considered
    Figure 11. Product Picture of Polyvalent Anti-Venom
    Figure 12. Product Picture of Monovalent Anti-Venom
    Figure 13. Global Anti-Venom Market Share by Type in 2022 & 2029
    Figure 14. Global Anti-Venom Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 15. Global Anti-Venom Sales Market Share in Value by Type (2018-2029)
    Figure 16. Global Anti-Venom Sales by Type (2018-2029) & (K Vials)
    Figure 17. Global Anti-Venom Sales Market Share in Volume by Type (2018-2029)
    Figure 18. Global Anti-Venom Price by Type (2018-2029) & (USD/Vial)
    Figure 19. India Anti-Venom Market Share by Type in 2022 & 2029
    Figure 20. India Anti-Venom Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 21. India Anti-Venom Sales Market Share in Value by Type (2018-2029)
    Figure 22. India Anti-Venom Sales by Type (2018-2029) & (K Vials)
    Figure 23. India Anti-Venom Sales Market Share in Volume by Type (2018-2029)
    Figure 24. India Anti-Venom Price by Type (2018-2029) & (USD/Vial)
    Figure 25. Product Picture of Non-profit Institutions
    Figure 26. Product Picture of Hospitals and Clinic
    Figure 27. Global Anti-Venom Market Share by Application in 2022 & 2029
    Figure 28. Global Anti-Venom Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 29. Global Anti-Venom Sales Market Share in Value by Application (2018-2029)
    Figure 30. Global Anti-Venom Sales by Application (2018-2029) & (K Vials)
    Figure 31. Global Anti-Venom Sales Market Share in Volume by Application (2018-2029)
    Figure 32. Global Anti-Venom Price by Application (2018-2029) & (USD/Vial)
    Figure 33. India Anti-Venom Market Share by Application in 2022 & 2029
    Figure 34. India Anti-Venom Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 35. India Anti-Venom Sales Market Share in Value by Application (2018-2029)
    Figure 36. India Anti-Venom Sales by Application (2018-2029) & (K Vials)
    Figure 37. India Anti-Venom Sales Market Share in Volume by Application (2018-2029)
    Figure 38. India Anti-Venom Price by Application (2018-2029) & (USD/Vial)
    Figure 39. Americas Anti-Venom Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 40. Americas Anti-Venom Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 41. Americas Anti-Venom Sales by Type (2018-2029) & (K Vials)
    Figure 42. Americas Anti-Venom Sales Market Share in Volume by Type (2018-2029)
    Figure 43. Americas Anti-Venom Sales by Application (2018-2029) & (K Vials)
    Figure 44. Americas Anti-Venom Sales Market Share in Volume by Application (2018-2029)
    Figure 45. United States Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Canada Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Mexico Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. EMEA Anti-Venom Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 50. EMEA Anti-Venom Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 51. EMEA Anti-Venom Sales by Type (2018-2029) & (K Vials)
    Figure 52. EMEA Anti-Venom Sales Market Share in Volume by Type (2018-2029)
    Figure 53. EMEA Anti-Venom Sales by Application (2018-2029) & (K Vials)
    Figure 54. EMEA Anti-Venom Sales Market Share in Volume by Application (2018-2029)
    Figure 55. Europe Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Middle East Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Africa Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. China Anti-Venom Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 59. China Anti-Venom Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 60. China Anti-Venom Sales by Type (2018-2029) & (K Vials)
    Figure 61. China Anti-Venom Sales Market Share in Volume by Type (2018-2029)
    Figure 62. China Anti-Venom Sales by Application (2018-2029) & (K Vials)
    Figure 63. China Anti-Venom Sales Market Share in Volume by Application (2018-2029)
    Figure 64. APAC Anti-Venom Sales in Volume Growth Rate 2018-2029 (K Vials)
    Figure 65. APAC Anti-Venom Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 66. APAC Anti-Venom Sales by Type (2018-2029) & (K Vials)
    Figure 67. APAC Anti-Venom Sales Market Share in Volume by Type (2018-2029)
    Figure 68. APAC Anti-Venom Sales by Application (2018-2029) & (K Vials)
    Figure 69. APAC Anti-Venom Sales Market Share in Volume by Application (2018-2029)
    Figure 70. Japan Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 71. South Korea Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 72. China Taiwan Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. Southeast Asia Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. India Anti-Venom Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. Anti-Venom Value Chain
    Figure 76. Anti-Venom Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart